Zhou DB, Cheng J, Zhang XH. Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199 analysis. World J Clin Cases 2024; 12(1): 15-23 [PMID: 38292648 DOI: 10.12998/wjcc.v12.i1.15]
Please LOGIN to submit a new comment.